About Kashi Clinical Laboratories
Kashi Clinical Laboratories is a Healthcare company based in Portland (United States) founded in 2006, and was acquired by Prairie Capital in June 2024. It provides laboratory testing for clinical pathology, genomics, and toxicology services. It operates on a B2B model. Kashi Clinical Laboratories offers products and services including Genetic Testing, Toxicology Testing, Virology Testing, and Clinical Pathology. Its focus areas include Diagnostics, Toxicology, Drug Metabolism and Laboratory Testing. Its competitors include Omniome, Tessera Therapeutics and Phase Genomics; 3 of its 3 listed competitors have raised funding.
Company details
Kashi Clinical Laboratories specializes in diagnostic testing, including clinical pathology, genomics, genetic testing, and toxicology. They deliver services to healthcare providers and patients through rapid turnaround times and EHR integration. Based in Portland, Oregon, they focus on molecular and environmental testing to support disease diagnosis and health monitoring. Their consultative approach ensures high-quality results for clinical trials and virology.
- Headquarters Portland, United States
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website kashilab.com
- Social LinkedIn X Facebook Instagram
- Acquired by Prairie Capital (Jun 2024)
- Investors
- Acquired byPrairie Capital
(Jun 2024)
Products & Services of Kashi Clinical Laboratories
Kashi Clinical Laboratories offers a comprehensive portfolio of products and services, including Genetic Testing, Toxicology Testing, Virology Testing, and Clinical Pathology.
Identifies genetic variations for disease diagnosis and risk assessment.
Analyzes drug sensitivity and metabolism for medical and environmental use.
Conducts PCR and serological tests to detect viral infections accurately.
Performs chemistry and hematology tests for overall health monitoring.
Investors in Kashi Clinical Laboratories
Kashi Clinical Laboratories has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Prairie Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Prairie Capital is focused on scaling lower middle market companies. | 1997 | prairie-capital.com | Chicago, United States |
Investor details for Kashi Clinical Laboratories
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Kashi Clinical Laboratories
6 people are tracked at Kashi Clinical Laboratories (4 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Masataka Hayashi | Vice President Of Finance | Leadership |
Zahra Kashi | CEO And Lab Director | Leadership |
Dawn Thomas Smith | Director Of Marketing | Leadership |
Sean Toddy | Vice President, HLA Client Development, Bone Marrow Transplant Services | Leadership |
Gabriel Caceres | Research Associate | Team |
Josh Murray | Senior Manager Diagnostic Partnerships - Transplant Diagnostics | Team |
Complete people profiles for Kashi Clinical Laboratories
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Kashi Clinical Laboratories
2 dated milestones of Kashi Clinical Laboratories across 18 years, from founding to its latest funding, stage changes and deals.
- Founded Kashi Clinical Laboratories is founded.
- Exit Acquired by Prairie Capital.
Competitors of Kashi Clinical Laboratories
Kashi Clinical Laboratories has 3 listed competitors in our database, 3 of them funded. They include Omniome, Tessera Therapeutics and Phase Genomics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| omniome.com | 2013 | San Diego, United States | $160.23M | 164 | Genome sequencing platform is provided for clinical diagnostics. | |
| tesseratherapeutics.com | 2017 | Cambridge, United States | $610M | 149 | New genome engineering technology is provided for treating multiple diseases. | |
| phasegenomics.com | 2015 | Seattle, United States | $5.75M | 19 | Laboratory and computational services for DNA proximity analysis are provided. |
Detailed competitors of Kashi Clinical Laboratories
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Toxicology
3 companies that operate in the same segment as Kashi Clinical Laboratories (Toxicology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutic solutions for food allergies are developed via antibody platforms. | 2019 | San Francisco, California, United States | USD 75 M | |||
Therapeutics for substance use disorders, including opioid-related conditions, are developed. | 2020 | Oakland, California, United States | USD 70 M | |||
Drug delivery solutions via single-walled carbon nanotubes are offered. | 2008 | Houston, Texas, United States | USD 2.5 M | USD 5.07 M | 9 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Kashi Clinical Laboratories
Complete news archive for Kashi Clinical Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kashi Clinical Laboratories
Kashi Clinical Laboratories was founded in 2006.
Kashi Clinical Laboratories is headquartered in Portland, United States. It is registered at Portland, Oregon, United States.
Kashi Clinical Laboratories specializes in diagnostic testing, including clinical pathology, genomics, genetic testing, and toxicology. They deliver services to healthcare providers and patients through rapid turnaround times and EHR integration. Based in Portland, Oregon, they focus on molecular and environmental testing to support disease diagnosis and health monitoring. Their consultative approach ensures high-quality results for clinical trials and virology.
Kashi Clinical Laboratories's top competitors include Tessera Therapeutics, Phase Genomics and Omniome.
Kashi Clinical Laboratories offers Genetic Testing, Toxicology Testing, Virology Testing, and Clinical Pathology.
Kashi Clinical Laboratories has 1 investor. Key investors include Prairie Capital.
Yes. Kashi Clinical Laboratories was acquired by Prairie Capital in June 2024.